Elevated expression levels of IL-37 have been observed in lung adenocarcinoma (LUAD) tumors, and the expression profiles of both IL-37 and its receptor SIGIRR are correlated with LUAD development and tumor stage [10]. This evidence concerns the gene IL37 and neoplasm.